Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daiichi Co., Ltd. (7643:JPX), powered by AI.
Daiichi Co., Ltd. is currently trading at ¥1,700. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Daiichi Co., Ltd. on Alpha Lenz.
Daiichi Co., Ltd.'s P/E ratio is 19.6.
“Daiichi Co., Ltd. trades at a P/E of 19.6 (fair value) with modest ROE of 5.8%.”
Ask for details →Daiichi Co., Ltd. is a distinguished entity within the consumer goods sector, primarily engaged in the wholesale distribution of pharmaceuticals, cosmetics, and health-related products. Established with a clear purpose to provide essential goods for health and wellness, Daiichi Co., Ltd. serves a fundamental role in sustaining and improving public health through its extensive network of distribution. This company characterizes its operations by leveraging strategic partnerships with numerous pharmacies and healthcare providers, ensuring a reliable supply chain for a diverse range of products. Recognized for its comprehensive catalog, it includes everything from vital medications to innovative beauty products, catering to a broad demographic. Daiichi Co., Ltd. holds significant market influence in the healthcare and beauty industries, contributing to the distribution efficiency and accessibility of crucial consumer goods. As a key player in Japan's domestic market, its activities not only reflect the growth of the healthcare and cosmetic sectors but also the evolving consumer patterns within these industries. By prioritizing quality and customer satisfaction, Daiichi Co., Ltd. underscores its commitment to maintaining robust public health and personal care standards.
“Daiichi Co., Ltd. trades at a P/E of 19.6 (fair value) with modest ROE of 5.8%.”
Ask for details →Daiichi Co., Ltd. (ticker: 7643) is a company listed on JPX in the Consumer Defensive sector (Grocery Stores). It has approximately 285 employees. Market cap is $19.2B.
The current price is 1,700 with a P/E ratio of 19.57x and P/B of 1.11x.
ROE is 5.75% and operating margin is 2.21%. Annual revenue is $59.2B.